Viewing Study NCT00421369


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2025-12-31 @ 3:21 AM
Study NCT ID: NCT00421369
Status: COMPLETED
Last Update Posted: 2013-03-22
First Post: 2007-01-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Augmentation of the Antidepressant Action of Sertraline With Triiodothyronine (T3)and Reboxetine: Clinical Efficacy, Adverse Effects and Predictors of Response.
Sponsor: Hadassah Medical Organization
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module